Silico Insights Inc., of Woburn, Mass., added David Schoenfeld, Cathy Wu and Sudhir Sahasrabudhe to its scientific board.
SurroMed Inc., of Mountain View, Calif., appointed Howard Schulman vice president of research and development.
Synaptica Ltd., of Oxford, UK, appointed Steven Butcher research director and a member of its management board.
Synt:em, of Nimes, France, appointed Luc-Andre Granier medical director and Gavril Pasternak to its scientific advisory board.
Triad Therapeutics Inc., of San Diego, appointed Joel Smith executive director for business development.
Venture Investment Management Corp., of Boston, appointed Dana Ono and David Marcus directors.
Xanthon Inc., of Research Triangle Park, N.C., appointed Neil Moore vice president of business development.
ZymoGenetics Inc., of Seattle, appointed Robert Whitehead senior vice president, chief business officer, and also a member of the executive management committee.